1-5 of 5
Kevin R. Petrie, PhD
Close
Sort by
Journal Articles

Inhibition of the PI3K/AKT/mTOR Pathway Leads to Down-Regulation of c-Myc and Overcomes Resistance to ATRA in Acute Myeloid Leukemia

Ronan T. Swords, MDPhDFRCPI FRCPath, Tino Schenk, PhD, Sven Stengel, PhD, Veronica Sylvina Gil, PhD, Kevin R. Petrie, PhD, Aymee Perez, PhD, Rodriguez Ana, Justin M. Watts, MD, Fernando Vargas, MD, Roy Elias, Arthur Zelent, PhD
Journal: Blood
Blood (2015) 126 (23): 1363.
https://doi.org/10.1182/blood.V126.23.1363.1363
Published: 2015
Journal Articles

HDAC9 Expression Is Deregulated in Malignant B-Cell Lymphomas in Particular in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma

Elena Cubedo, PhD, Veronica Sylvina Gil, PhD, Chae Hwa Kim, German Campuzano-Zuluaga, MD, Nitin Kumar Agarwal, PhD, Louise Howell, BSc, Kevin R. Petrie, PhD, Francisco Vega, MD PhD, Arthur Zelent, PhD
Journal: Blood
Blood (2014) 124 (21): 5374.
https://doi.org/10.1182/blood.V124.21.5374.5374
Published: 2014
Journal Articles

Modulation of Histone H3K4 and H3K27 Methylation Levels Via Pharmacological Inhibition of LSD1 and Degradation of the EZH2-Containing Polycomb Repressive Complex 2 Stimulates ATRA-Mediated Differentiation of AML Cells.

Kevin R. Petrie, PhD, Tino Schenk, PhD, Manuel Boix Chornet, PhD, Louise Howell, John E Dick, PhD, Victor E Marquez, PhD, Laurence J Marton, MD, Patrick M Woster, PhD, Robert A Casero, Jr., PhD, Arthur Zelent, PhD
Journal: Blood
Blood (2009) 114 (22): 1046.
https://doi.org/10.1182/blood.V114.22.1046.1046
Published: 2009
Journal Articles

Ectopic Expression of HDAC9 in Murine Lymphoid System Leads to Altered Lymphocyte Numbers and Proliferation as Well as Predisposition to Tumorigenesis.

Veronica S. Gil, BSc, Louise M.C. Howell, BSc, Jenny Yeung, PhD, Kevin R. Petrie, PhD, Adrian Smith, PhD, Neil Sebire, MD, Estela Matutes, MD, PhD, Andy Wotherspoon, MD, Tariq Enver, PhD, Eric So, PhD, Arthur Zelent, PhD
Journal: Blood
Blood (2007) 110 (11): 376.
https://doi.org/10.1182/blood.V110.11.376.376
Published: 2007
Journal Articles

Retinoblastoma Protein and the Leukemia-Associated PLZF Transcription Factor Interact To Repress Target Gene Promoters.

Kevin R. Petrie, PhD, Fabien Guidez, PhD, Jun Zhu, PhD, Gareth Owen, PhD, Yat Peng Chew, Samuel Waxman, MD, Jonathan D. Licht, MD, PhD, Sibylle Mittnacht, PhD, Zelent Arthur, PhD
Journal: Blood
Blood (2007) 110 (11): 1240.
https://doi.org/10.1182/blood.V110.11.1240.1240
Published: 2007